Article

AMD linked with race, study finds

A population-based study showed that white patients are more likely to show signs of age-related macular degeneration than black patients.

Baltimore-A population-based study showed that white patients are more likely to show signs of age-related macular degeneration (AMD) than black patients.

Patients that were aged 65 years and older showed no difference in the prevalence of drusen, based on race. White patients were more likely than blacks to have drusen 64 mm or larger (36% versus 28%), drusen 125 mm or larger (11% versus 5%), and confluent drusen (16% versus 8%) in the central macular zone (p = 0.001 for all), reported Susan Bressler, MD, Wilmer Eye Institute, Johns Hopkins University, and colleagues.

White patients were significantly more likely to have focal hyperpigmentation in the central zone than black patients (7.1% versus 2.5%, p = 0.001), according to the study published in the February issue of the Archives of Ophthalmology.

The results, the researchers said, "suggest that black individuals have similar rates of fundus features in the pericentral zone but do not seem to manifest [AMD] features, particularly those that impart risk for disease progression, in the central zone."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.